Logo image of EVMT.CA

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Stock Price, Forecast & Analysis

Canada - TSX Venture Exchange - TSX-V:EVMT - CA30053H1055 - Common Stock

0.005 CAD
0 (0%)
Last: 5/6/2025, 7:00:00 PM

EVMT.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap300.85K
Revenue(TTM)48.34M
Net Income(TTM)-23.53M
Shares60.17M
Float50.77M
52 Week High0.21
52 Week Low0.01
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.29
PEN/A
Fwd PEN/A
Earnings (Next)08-11
IPO2014-03-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
EVMT.CA short term performance overview.The bars show the price performance of EVMT.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

EVMT.CA long term performance overview.The bars show the price performance of EVMT.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EVMT.CA is 0.005 CAD. In the past year, price decreased by -97.37%.

EVOME MEDICAL TECHNOLOGIES I / EVMT Daily stock chart

EVMT.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EVMT.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to EVMT.CA. Both the profitability and financial health of EVMT.CA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EVMT.CA Financial Highlights

Over the last trailing twelve months EVMT.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 4.5% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -66.99%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-140%
Sales Q2Q%-49.05%
EPS 1Y (TTM)4.5%
Revenue 1Y (TTM)-39.95%

EVMT.CA Forecast & Estimates

For the next year, analysts expect an EPS growth of -400% and a revenue growth -0.65% for EVMT.CA


Analysts
Analysts80
Price TargetN/A
EPS Next Y-400%
Revenue Next Year-0.65%

EVMT.CA Ownership

Ownership
Inst Owners9.89%
Ins Owners0.19%
Short Float %N/A
Short RatioN/A

About EVMT.CA

Company Profile

EVMT logo image Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Shirley, New York and currently employs 195 full-time employees. The company went IPO on 2014-03-28. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. The company offers concussion, fall screening and balance assessment and training programs.

Company Info

EVOME MEDICAL TECHNOLOGIES I

49 Natcon Drive

Shirley NEW YORK US

Employees: 195

EVMT Company Website

EVMT Investor Relations

Phone: 18007606826

EVOME MEDICAL TECHNOLOGIES I / EVMT.CA FAQ

What does EVMT do?

Evome Medical Technologies, Inc. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Shirley, New York and currently employs 195 full-time employees. The company went IPO on 2014-03-28. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. The company offers concussion, fall screening and balance assessment and training programs.


What is the stock price of EVOME MEDICAL TECHNOLOGIES I today?

The current stock price of EVMT.CA is 0.005 CAD.


Does EVOME MEDICAL TECHNOLOGIES I pay dividends?

EVMT.CA does not pay a dividend.


How is the ChartMill rating for EVOME MEDICAL TECHNOLOGIES I?

EVMT.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the growth outlook for EVOME MEDICAL TECHNOLOGIES I?

The Revenue of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) is expected to decline by -0.65% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


What is the market capitalization of EVMT stock?

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a market capitalization of 300.85K CAD. This makes EVMT.CA a Nano Cap stock.